Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gringeri

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Blood|January 1, 1997
Hemophilia and nonprogressing human immunodeficiency virus type 1 infectionE Vicenzi, P Bagnarelli, E Santagostino, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
C-C chemokines, pivotal in protection against HIV type 1 infectionD Zagury, A Lachgar, V Chams, et al.
Journal of Human Virology|April 9, 1999
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccineJ F Zagury, A Sill, W Blattner, et al.
American Journal of Hematology|July 10, 2001
Therapeutic choices for patients with hemophilia and high-titer inhibitorsR Kulkarni, L M Aledort, E Berntorp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus reportJ Astermark, C Altisent, A Batorova, et al.
The Journal of Infectious Diseases|July 7, 2000
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infectionA Brambilla, C Villa, G Rizzardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statementE C Rodriguez-Merchan, A Rocino, B Ewenstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 28, 2017
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statementA Iorio, E Iserman, V Blanchette, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2013
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA studyA Gringeri, C Leissinger, P A Cortesi, et al.
Journal of Thrombosis and Haemostasis : JTH|March 30, 2010
Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic reviewA Iorio, S Halimeh, S Holzhauer, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Blood|January 1, 1997
Hemophilia and nonprogressing human immunodeficiency virus type 1 infectionE Vicenzi, P Bagnarelli, E Santagostino, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
C-C chemokines, pivotal in protection against HIV type 1 infectionD Zagury, A Lachgar, V Chams, et al.
Journal of Human Virology|April 9, 1999
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccineJ F Zagury, A Sill, W Blattner, et al.
American Journal of Hematology|July 10, 2001
Therapeutic choices for patients with hemophilia and high-titer inhibitorsR Kulkarni, L M Aledort, E Berntorp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus reportJ Astermark, C Altisent, A Batorova, et al.
The Journal of Infectious Diseases|July 7, 2000
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infectionA Brambilla, C Villa, G Rizzardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statementE C Rodriguez-Merchan, A Rocino, B Ewenstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 28, 2017
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statementA Iorio, E Iserman, V Blanchette, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2013
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA studyA Gringeri, C Leissinger, P A Cortesi, et al.
Journal of Thrombosis and Haemostasis : JTH|March 30, 2010
Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic reviewA Iorio, S Halimeh, S Holzhauer, et al.
Pageof 13